Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017168 (
gastroesophageal reflux disease
)
11,783
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pneumatic dilatation of the cardia is an effective procedure to treat patients suffering from achalasia. Eighty percent of these patients can be expected to have excellent or good results for 6 years after the first dilatation. A repeat dilatation should be performed as soon as the patient has recurrent symptoms, usually every 2 years. Calcium channel blockers (nifedipine and verapamil) or nitrates (isosorbide dinitrate) decrease LES pressure but do little to the clinical symptomatology of patients with achalasia; however such drug therapy may be tried as an adjunct in patients who remain symptomatic after pneumatic dilatations or myotomy. Pneumatic dilatation and surgical myotomy both reduce LES pressure; with pneumatic dilatation, enough residual LES pressure is retained to prevent
gastroesophageal reflux
. Indeed,
reflux esophagitis
seems to occur more often after surgery than after forceful dilatations. We think that pneumatic dilatation should be performed as the primary therapy and surgery reserved for the failures of this procedure.
...
PMID:Non-surgical management of achalasia. 163 43
Prolonged esophageal pH monitoring is considered to be the most sensitive and specific test for the diagnosis of
gastroesophageal reflux disease
(
GERD
). However, the role of pH monitoring in predicting the clinical and endoscopic response of
reflux esophagitis
is not well defined. In this study, 106 patients with moderate to severe symptoms of
GERD
and esophagitis (grades 0-IV) by endoscopy were initially studied by ambulatory esophageal pH monitoring, and their clinical response to standard H2 antagonist therapy was monitored at 8 wk. Refractory patients were defined as those who failed to heal and/or had intractable reflux symptoms after 8 wk of H2 antagonist therapy, and who required continuous therapy with higher doses of H2 antagonists, addition of prokinetic agents, or omeprazole. There was a positive correlation (r = 0.89) between endoscopic severity of esophagitis upon entry into the study and refractoriness to standard medical therapy. However, there were no differences in the various pH parameters analyzed between the 58 patients who responded and the 48 patients who were refractory to medical therapy, regardless of the endoscopic grading of their esophagitis. We conclude that 24-h ambulatory esophageal pH monitoring does not predict refractoriness of
reflux esophagitis
to standard therapy. The decision for more aggressive methods of treatment probably requires assessment of symptomatic and endoscopic response after 8 week standard H2 antagonist therapy.
...
PMID:Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis. 167 86
Herein we describe two patients with medically refractory, severe
reflux esophagitis
after vertical banded gastroplasty for morbid obesity. Neither patient had symptoms of reflux preoperatively. Both patients underwent conversion to a vertical Roux-en-Y gastric bypass, an operation that prevents acid and peptic reflux and maintains a weight-reducing anatomy. Symptoms of
gastroesophageal reflux
are common (they occur in approximately 38% of patients) after vertical banded gastroplasty has been performed. Patients with unusually severe reflux may require operative management.
...
PMID:Severe reflux esophagitis after vertical banded gastroplasty for treatment of morbid obesity. 173 88
We present our experience with ten cases of laparoscopic Nissen's fundoplication.
Reflux esophagitis
is a very common disease and is associated with a lack of response to medical treatment in a significant number of cases, yet the rate of referral to a surgeon is extremely low. We believe that the endoscopic treatment of this disease is much less invasive and more cost-effective and is associated with lower rates of complications. Indeed, our patients left the hospital at 24-48 h post-surgery and were involved in their regular activities at 4 days to 1 week thereafter. Neither mortality nor complications associated with the procedure were encountered. We believe that the feasibility and the benefits of this procedure will lead to earlier referral and hence to avoidance of long-term complications of
gastroesophageal reflux disease
.
...
PMID:Laparoscopic Nissen's fundoplication: preliminary report on ten cases. 183 73
Between 1967 and 1989, 60 patients underwent pneumatic dilation of the cardia at our institution. Of these, 33 had not undergone any previous treatment (group 1), whereas 27 presented with recurrent dysphagia after a failure of surgical treatment (group 2). In this series there was no procedure-related mortality and a perforation occurred only in 1 patient who was treated conservatively. The mean follow-up was similar in both groups (44 and 49 months, respectively). The results of pneumatic dilation were either excellent or good in 61% of group 1 patients, and in 76% of group 2 patients.
Reflux oesophagitis
requiring medical therapy occurred in 1 group 2 patient. We conclude that pneumatic dilation is a safe and relatively effective procedure in patients with achalasia. Patients with a failed Heller myotomy seem to respond better than patients without previous surgery. However, the risk of gastro-
oesophageal reflux
after pneumatic dilation should not be underestimated.
...
PMID:Early and long-term results of pneumatic dilation in the treatment of oesophageal achalasia. 187 77
Fifty two patients with abnormal acid gastro-
oesophageal reflux
were studied by simultaneous oesophageal pH monitoring and continuous aspiration for 16 hours. Aspirates (from discrete two hour periods) were analysed for volume, pH, bile acids (conjugated and unconjugated), trypsin, and pepsin. The results were compared with pH changes and degree of oesophagitis. Patients with oesophagitis had greater acid reflux than those without, but patients with stricture and Barrett's oesophagus had similar acid reflux to those with uncomplicated erosive oesophagitis. Pepsin concentrations were highest in patients with stricture and Barrett's oesophagus particularly during nocturnal periods. Conjugated bile acids were detected in 75% of patients, mainly during the night, but only 2% of aspirates contained concentrations likely to be cytotoxic. Unconjugated bile acids were not detected, and trypsin was seldom found.
Reflux oesophagitis
is caused by acid and pepsin. Bile acids and trypsin are probably unimportant.
...
PMID:Composition of gastro-oesophageal refluxate. 195 60
The author discusses the role of prokinetic agents, such as bethanechol, metoclopramide, domperidone, and cisipride in the management of
gastroesophageal reflux disease
. These agents address the upper gastrointestinal motility disturbances that contribute to this disease and therefore have an important role in the acute and long-term medical management of
reflux esophagitis
.
...
PMID:Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. 197 2
Gastroesophageal reflux disease
is a very common condition that is usually manifested by heartburn or regurgitation.
Reflux esophagitis
, caused by mucosal exposure to the backflow of caustic gastric contents, is primarily a result of lower esophageal sphincter dysfunction. Diagnostic workup varies but commonly includes esophagoscopy, 24-hour esophageal pH monitoring, and radiography of the upper gastrointestinal tract. Treatment, which progresses from simple life-style changes and antacids to histamine2 receptor antagonists to omeprazole (Prilosec) or surgery, is tailored to individual needs and is generally successful.
...
PMID:Gastroesophageal reflux disease. When antacids aren't enough. 203 Oct 30
The history, physical examination, and the results of the upper gastrointestinal series, esophageal manometry, 24-h pH recording, endoscopy, and biopsy are reviewed in 16 children (mean age of 10.6 years, range of 3 years 5 months to 15 years 3 months) who presented to the Alberta Children's Hospital with dysphagia ("food-sticking") without previously identified provocative disorders since January 1985. Of the 16 patients, 11 had had intermittent obstruction, and 7 had had intervention to relieve obstruction (2 Heimlich maneuvers, 1 intravenous glucagon, and 4 endoscopy after failure of intravenous glucagon). Although only five children had a recent history suggestive of
gastroesophageal reflux
, 12 had histologic evidence of
reflux esophagitis
(including 1 with a peptic stricture, 1 with "nutcracker" esophagus, and 1 with esophageal dysmotility characteristic of Down's syndrome) and all responded clinically to antireflux therapy. Of the remaining four patients, one had extrinsic esophageal compression from a vascular ring (right aortic arch with left ligamentum arteriosum), one had a single and another had recurrent episodes of food-sticking without any identified abnormality, and one declined investigation. In childhood, dysphagia may be the presenting symptom of
reflux esophagitis
in the absence of a history suggestive of
gastroesophageal reflux
and without evidence of a peptic stricture.
...
PMID:The role of gastroesophageal reflux in pediatric dysphagia. 205 Dec 65
In order to investigate the response of
gastroesophageal reflux
after medically induced healing of esophagitis and its relation to the occurrence of relapse during prophylactic treatment, 20 patients with erosive/ulcerative esophagitis underwent 24 hour esophageal pH monitoring before and after healing achieved with 12 to 24 weeks with ranitidine 150 or 300 mg bd. Compared with pretreatment values, after macroscopic healing, a significant reduction in daytime median percentage of reflux time and median number of reflux episodes lasting more than 5 min were observed, whereas during the night time reflux frequency and severity did not change. During maintenance treatment with ranitidine at half the acute dosage five of the six patients who had shown no improvement in
gastroesophageal reflux
after acute healing, relapsed. These results suggest that, in contrast to previous work, a decrease in
gastroesophageal reflux
in patients with
reflux esophagitis
can be achieved after macroscopic healing obtained with H2-antagonists, and that the occurrence of such a reduction after acute healing is predictive of a good response to long-term treatment.
...
PMID:[Reflux esophagitis: therapy with H2-blockers, and motility disorders]. 206 75
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>